SCHEMBL5300370

SCHEMBL5300370

Clc1ccn2cc(-c3ccc(-c4ccccc4)cc3)nc2c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A3 P47895 6/20 0.61
ALDH1A1 P00352 2/20 0.61
NPC1 O15118 8/20 0.60
RAB9A P51151 8/20 0.60
SCD O00767 1/20 0.60
TLR9 Q9NR96 1/20 0.58
ALDH1A2 O94788 2/20 0.57
TP53 P04637 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
SLC2A1 P11166 1/20 0.51
PLK4 O00444 1/20 0.50
JAK2 O60674 1/20 0.50
RET P07949 1/20 0.50
PIM1 P11309 1/20 0.50
FGFR1 P11362 1/20 0.50
FLT1 P17948 1/20 0.50
KDR P35968 1/20 0.50
FLT3 P36888 1/20 0.50
PIM3 Q86V86 1/20 0.50
ALK Q9UM73 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28396792 0.97 TLR9 (0.61) ALDH1A3ALDH1A1NPC1RAB9ASCD
SCHEMBL1691462 0.89 RAB9A (0.66) ALDH1A3ALDH1A1NPC1RAB9ASCD
SCHEMBL13325781 0.85 SCD (0.65) ALDH1A3ALDH1A1NPC1RAB9ASCD
SCHEMBL22907197 0.84 SMN1; SMN2 (0.74) ALDH1A3ALDH1A1NPC1RAB9ASCD
SCHEMBL2511536 0.84 NPC1 (0.68) ALDH1A3ALDH1A1NPC1RAB9ASCD
SCHEMBL13325776 0.83 TLR9 (0.65) ALDH1A3ALDH1A1NPC1RAB9ASCD
Bromide SCHEMBL1691791 0.83 NPC1 (0.67) ALDH1A3ALDH1A1NPC1RAB9ASCD
SCHEMBL13325899 0.81 SMN1; SMN2 (0.79) ALDH1A3ALDH1A1NPC1RAB9ASCD
SCHEMBL13325729 0.81 NPC1 (0.72) ALDH1A3ALDH1A1NPC1RAB9ATLR9
SCHEMBL25790043 0.81 RAB9A (0.73) ALDH1A3ALDH1A1NPC1RAB9AALDH1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007034282-A2 DIARYL-IMIDAZOLE COMPOUNDS CONDENSED WITH A HETEROCYCLE AS C3A RECEPTOR ANTAGONISTS PFIZER PRODUCTS INC. (US) 2007-03-29 WO disclosed